Page last updated: 2024-08-25

hederagenin and Acute Kidney Injury

hederagenin has been researched along with Acute Kidney Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Han, RY; Jia, J; Liu, XH; Tan, RZ; Wang, L; Xie, KH; Zhong, X	1

Other Studies

1 other study(ies) available for hederagenin and Acute Kidney Injury

Article	Year
Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway. International immunopharmacology, 2022, Volume: 112 Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; beta Catenin; Cisplatin; Disease Models, Animal; Inflammation; Kidney; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Oleanolic Acid; RNA, Long Noncoding; RNA, Messenger; RNA, Small Interfering; Saponins	2022

Article

Year

Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.

International immunopharmacology, 2022, Volume: 112

Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; beta Catenin; Cisplatin; Disease Models, Animal; Inflammation; Kidney; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Oleanolic Acid; RNA, Long Noncoding; RNA, Messenger; RNA, Small Interfering; Saponins

2022